当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2019年第7期
编号:13348484
乳腺癌术后并发卵巢癌的microRNA标志物筛选及临床早期预测研究(4)
http://www.100md.com 2019年3月5日 《中国医药导报》 2019年第7期
     [9] Antoniou A,Pharoah PD,Narod S,et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history:a combined analysis of 22 studies [J]. Am J Hum Genet,2003,72(5):1117-1130.

    [10] Nelson HD,Huffman LH,Fu R,et al. Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility:Systematic Evidence Review for the U.S. Preventive Services Task Force [J]. Ann Intern Med ......
上一页1 2 3 4

您现在查看是摘要页,全文长 3185 字符